CAS: 904326-93-8; 6-Morpholino-3-Pyridineboronic Acid

该化合物是一种有机化合物,其特点是,在一条环虫状环上有一个附着的碱酸性功能组,再用一碱性动物来替代.该化合物通常具有诸如白到白的固体,水和甲醇等极地溶剂中可溶解,并具有中度分子重量等特性.乙酸组因有能力与二醇形成可逆的共价结合,从而在包括药用化学和材料科学在内的各种应用中发挥作用.氨基环有助于该化合物的基本性和氢联结潜力,增强其再活性和与生物目标的相互作用.此外,该化合物还可能展示生物活动,特别是在药物开发方面,因为人们经常探讨其对于酶抑制作用以及作为复合分子的建筑块的作用.

结构式图片

相似化合物

485799-04-0 1191062-85-7 1218790-86-3

欧盟法规

C&L通报

上下游产品

CAS号200064-11-5 5-溴-2-吗啉吡啶 | CAS号24255-25-2 2-吗啉基吡啶 | CAS号26820-62-2 2-吗啉基-5-硝基吡啶 | CAS号24255-27-4 4-(3-硝基-2-吡啶基)吗啉

合成工艺路线路线简述

    📜4-(5-溴吡啶-2-基)吗啉置于正丁基锂,硼酸三异丙酯体系中,用 乙醚,正己烷 作为反应溶剂,化学反应 4.0H,反应生成 6-(4-吗啉基)-3-吡啶硼酸
    参考文献:新型的双芳基取代的噻唑和恶唑类化合物是高活性和选择性的过氧化物酶体增殖物激活受体δ激动剂.
    标题:新型的双芳基取代的噻唑和恶唑类化合物是高活性和选择性的过氧化物酶体增殖物激活受体δ激动剂.
    摘要:从高通量筛选到高效和选择性的过氧化物酶体增殖物激活受体δ(pparδ)激动剂的发现,合成和优化了化合物1.详细介绍了该系列中的合成和构效关系.基于通用的ppar药效团模型示意图,支架1将其分为头基,接头和尾基,并使用体外ppar反式激活分析对ppar激活进行了优化.有效和选择性的pparδ活化需要一个(2-甲基苯氧基)乙酸头基,一个柔性连接基和一个带有两个疏水性芳基取代基的五元杂芳族中心环.这些芳基取代基的微调导致了一系列高效且选择性的化合物(例如化合物38C)在小鼠体内表现出出色的药代动力学特性.在体内急性给药模型中,该阵列的选定成员显示出可诱导丙酮酸脱氢酶激酶4(pdk4)和解偶联蛋白3(ucp3)的表达,这些基因已知参与能量稳态并受其调节.骨骼肌中的pparδ.
    DOI:10.1021/jm9007399

    海关参考信息

    专利信息


    专利号:US-11225655-B2
    优先权日:2010-04-16
    标题:Bi-functional complexes and methods for making and using such complexes
    发明人:GOULIAEV ALEX HAAHR; FRANCH THOMAS; GODSKESEN MICHAEL ANDERS; JENSEN KIM BIRKEBAEK
    权利人:GOULIAEV ALEX HAAHR; FRANCH THOMAS; GODSKESEN MICHAEL ANDERS; JENSEN KIM BIRKEBAEK; NUEVOLUTION AS
    摘要:The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.

    专利号:US-11066447-B2
    优先权日:2016-08-08
    标 题:Aureobasidium derivatives and methods of synthesis
    发明人:WUTS PETER; ELHAMMER AKE P
    权利人:AUREOGEN BIOSCIENCES INC; AUEROGEN BIOSCIENCES INC
    摘要:In general, the invention relates to AbA derivatives that are useful for treating infection. These novel compounds are shown to be effective in treating various fungal infections. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various fungal infections.

    专利号:US-9988371-B2
    优先权日:2014-06-03
    标 题:Benzimidazole analogues and related methods
    发明人:LI HONG-YU; FRETT BRENDAN; SANTORO MASSIMO; CARLOMAGNO FRANCESCA
    权利人:UNIV ARIZONA; UNIV FEDERICO II; UNIV ARIZONA
    摘要:The invention relates to compounds of the formula (VIII) wherein the moieties R 1 , R 2 , R 3 , R 4 , and R 5 are as defined in the specification, and salts thereof, as well as their use, methods of use for them, methods of their synthesis, and the like. The compounds are protein tyrosine kinase inhibitors and can be used in the treatment of various cancer diseases and cancer-associated pain.

    专利号:WO-2018031521-A1
    优先权日:2016-08-08
    标 题:Aureobasidium derivatives and methods of synthesis

    专利号:US-2019292225-A1
    优先权日:2016-08-08
    标 题:Aureobasidium derivatives and methods of synthesis

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知